Evidence map›Paper›PMID 41377582›Full record

ArticleMaterials today. Bio2025

Development of a three-dimensional airway organoid-pillar dish (3D AO-PD) platform for particulate matter-induced airway toxicity analysis.

Eunyoung Lee, Sang-Yun Lee, Yu-Jeong Seong, Jeong Uk Lim, Jae-Young Jeong, Ji-O Ryu, Yongki Hwang, Hyobin Won, Seok Whan Moon, Young Du Kim and 7 more

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eunyoung LeeDivision of Pulmonology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Sang-Yun LeeGraduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, 34134, Republic of Korea.
Yu-Jeong SeongDivision of Pulmonology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Jeong Uk LimDivision of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Jae-Young JeongDepartment of Biomedical Engineering, Gachon University, Seongnam, 13120, Republic of Korea.
Ji-O RyuDepartment of Biomedical Engineering, Gachon University, Seongnam, 13120, Republic of Korea.
Yongki HwangDivision of Pulmonology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Hyobin WonDivision of Pulmonology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Seok Whan MoonDepartment of Thoracic and Cardiovascular Surgery, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Young Du KimDepartment of Thoracic and Cardiovascular Surgery, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Kyung Soo KimDepartment of Thoracic and Cardiovascular Surgery, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Mi Hyoung MoonDepartment of Thoracic and Cardiovascular Surgery, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Seung Keun YoonDepartment of Thoracic and Cardiovascular Surgery, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Yeoun Eun SungDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Meejeong KimDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Bosung KuCentral R & D Center, Medical & Bio Decision (MBD) Co., Ltd, Suwon, 16229, Republic of Korea.
Dong Woo LeeDepartment of Biomedical Engineering, Gachon University, Seongnam, 13120, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Particulate matter (PM) is a major component of air pollution and is associated with respiratory diseases and lung dysfunction. Physiologically relevant models are essential for studying PM-induced airway responses in vitro. Conventional two-dimensional (2D) monolayer models comprising only bronchial epithelial cells are limited in their ability to mimic the complex structure of airway tissue. In contrast, three-dimensional (3D) airway organoids contain basal, ciliated, and goblet cells, which better reflect airway architecture. However, the standardization of 3D cultures has been a major challenge. In the present study, to address this, we developed the 3D Airway Organoid-Pillar Dish (AO-PD) model, a platform that enables reproducible formation of standardized 3D airway. We compared this model with a 2D monolayer model under PM exposure. The 3D AO-PD model showed higher cell viability and significant inflammatory and epithelial-mesenchymal transition responses than that of the 2D model. These results indicate that the 3D AO-PD model more accurately reflects PM-induced airway damage and provides greater resistance to environmental insults owing to its pseudostratified epithelial structure and enhanced cell-cell interactions. Thus, the 3D AO-PD model serves as a robust in vitro platform for investigating PM-induced airway toxicity and inflammation-related responses.

Indexed as

Airway organoidsParticulate matterThree-dimensional airway organoid-pillar dishThree-dimensional cell cultureToxicity analysis

Identifiers

PMID41377582
PMCPMC12689186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.